US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 38.700
  • -0.470-1.20%
Close Jul 12 16:00 ET
  • 38.700
  • 0.0000.00%
Post 16:20 ET
1.89BMarket Cap13.30P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Amphastar Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

171.84M

+22.72%
EPS(YoY)

0.81

+62.00%
Analyst Rating

Buy

Jul 14, 2024

Amphastar Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 198.115M--
--2024/Q2-- / 171.243M--
May 8, 20242024/Q1171.800M / 174.713M--
Feb 28, 20242023/Q4178.105M / 173.326M--
Nov 8, 20232023/Q3180.556M / 173.800M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 198.115M--
--2024/Q2-- / 171.243M--
May 8, 20242024/Q1171.800M / 174.713M--
Feb 28, 20242023/Q4178.105M / 173.326M--
Nov 8, 20232023/Q3180.556M / 173.800M--

Unlock Free Earnings Estimates

Amphastar Pharmaceuticals Earnings Reports

  • Amphastar Pharmaceuticals | 10-Q: Quarterly report

    May 10 15:05 ET

  • Amphastar Pharmaceuticals | 10-K: Annual report

    Feb 29 22:45 ET

  • Amphastar Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 16:24 ET

  • Amphastar Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 18:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 14, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Cannabis
    Cannabis
    Intraday+0.67%